Traders price Strava's IPO closing market cap most heavily in the 2B–3B range because its last confirmed private valuation stands at $2.2 billion from the May 2025 round, with no updated financials or public S-1 available after the confidential filing in early 2026 and the missed spring window. This anchors the leading outcome near the prior mark while the 7B–10B bucket trails closely, reflecting uncertainty over subscription conversion from its large free user base, revenue growth around $415 million, and broader consumer-health IPO multiples. Preparatory moves such as adding experienced board members and restricting API access signal readiness without fresh metrics that could justify a sharp re-rating. The spread remains tight because timing risks could delay any debut past 2027, while stronger user trends or favorable market conditions might lift the debut multiple.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоStrava IPO Closing Market Cap
2B–3B 30%
<2B 9.7%
4B–5B 10%
3B–4B 5.8%
$90,757 Обс.
$90,757 Обс.
<2B
10%
2B–3B
30%
3B–4B
6%
4B–5B
10%
5B–7B
5%
7B–10B
22%
10B–15B
5%
15B+
4%
No IPO before 2028
7%
2B–3B 30%
<2B 9.7%
4B–5B 10%
3B–4B 5.8%
$90,757 Обс.
$90,757 Обс.
<2B
10%
2B–3B
30%
3B–4B
6%
4B–5B
10%
5B–7B
5%
7B–10B
22%
10B–15B
5%
15B+
4%
No IPO before 2028
7%
If no Strava IPO occurs by December 31, 2027, 11:59 PM ET, this market will resolve to "No IPO before 2028".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Strava’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Ринок відкрито: Jan 14, 2026, 5:30 PM ET
Вирішувач
0x2F5e3684c...If no Strava IPO occurs by December 31, 2027, 11:59 PM ET, this market will resolve to "No IPO before 2028".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Strava’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Вирішувач
0x2F5e3684c...Traders price Strava's IPO closing market cap most heavily in the 2B–3B range because its last confirmed private valuation stands at $2.2 billion from the May 2025 round, with no updated financials or public S-1 available after the confidential filing in early 2026 and the missed spring window. This anchors the leading outcome near the prior mark while the 7B–10B bucket trails closely, reflecting uncertainty over subscription conversion from its large free user base, revenue growth around $415 million, and broader consumer-health IPO multiples. Preparatory moves such as adding experienced board members and restricting API access signal readiness without fresh metrics that could justify a sharp re-rating. The spread remains tight because timing risks could delay any debut past 2027, while stronger user trends or favorable market conditions might lift the debut multiple.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено



Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання